GSK 461364,
GSK-461364,
GSK461364,
GSK461364,
929095-18-1,
GSK-461364,
GSK 461364,
5-[6-[(4-Methyl-1-piperazinyl)methyl]-1h-benzimidazol-1-yl]-3-[(1r)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-thiophenecarboxamide,
(R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide,
UNII-8QO27TK6Q4,
GSK461364A,
GSK-461364A,
8QO27TK6Q4,
CHEMBL1908394,
ZHJGWYRLJUCMRT-QGZVFWFLSA-N,
SCHEMBL310080,
GTPL5684,
C27H28F3N5O2S,
CHEBI:91333,
CTK8B7590,
DTXSID60239197,
5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide,
BCP01720,
EX-A1728,
KS-00000OL5,
ABP000820,
ANW-57776,
BDBM50355500,
MFCD12755419,
s2193,
ZINC43154472,
AKOS015904545,
BCP9000744,
CS-0069,
NCGC00263112-01,
2-Thiophenecarboxamide, 5-(6-((4-methyl-1-piperazinyl)methyl)-1H-benzimidazol-1-yl)-3-((1R)-1-(2-(trifluoromethyl)phenyl)ethoxy)-,
5-(6-((4-Methylpiperazin-1-yl)methyl)-1H-benzimidazol-1-yl)-3-(((1R)-1-(2-(trifluoromethyl)phenyl)ethyl)oxy)thiophene-2-carboxamide,
AC-23167,
AN-16808,
BC659980,
HY-50877,
AX8211355,
GSK461364/GSK-461364,
TC-146521,
A8441,
FT-0772568,
SW220052-1,
X7374,
GSK461364A, >=98% (HPLC),
W-5534,
BRD-K92428232-001-01-5,
I14-17032,
929095-18-1 , GSK 461364,
5-[6-[(4-Methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]eth,
5-{6-[(4-methylpiperazin-1-yl)methyl]-1,3-benzodiazol-1-yl}-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide,
5-{6-[(4-methylpiperazin-1-yl)methyl]-1H-1,3-benzodiazol-1-yl}-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide,
5-{6-[(4-Methylpiperazin-1-yl)methyl]-1H-benzimidazol-1-yl}-3-{(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy}thiophene-2-carboxamide,
D08RMJ,
cc-630,
ACN-037082,
CB11660,
A10442,
5-(6-((4-METHYLPIPERAZIN-1-YL)METHYL)-1H-BENZO[D]IMIDAZOL-1-YL)-3-((R)-1-(2-(TRIFLUOROMETHYL)PHENYL)ETHOXY)THIOPHENE-2-CARBOXAMIDE,